CBIC Updated CIC Exam Questions and Answers by rosalie

The CBIC Certified Infection Control Exam Study Guide (6th edition) identifies prion diseases (such as Creutzfeldt-Jakob disease) as unique and extremely challenging from an infection prevention standpoint due to the extraordinary resistance of prions to conventional disinfection and sterilization methods. Prions are not destroyed by standard high-level disinfection, low-temperature sterilization, ethylene oxide, or hydrogen peroxide gas plasma, even when manufacturer instructions for use suggest these methods for routine pathogens.

Invasive neurologic procedures involving high-risk tissues (brain, spinal cord, posterior eye) pose the greatest transmission risk. When a reusable device such as an endoscope is used on high-risk tissue in a patient with known or suspected prion disease, and the device cannot tolerate validated prion-inactivation protocols, the Study Guide recommends removal from service and disposal.

While harsh chemical treatments such as 1N sodium hydroxide or high-concentration bleach combined with extended steam sterilization may be effective for heat-resistant surgical instruments, flexible endoscopes and similar devices cannot safely undergo these processes without damage. Therefore, reprocessing is not acceptable in this scenario.

Autoclaving alone and low-temperature sterilization methods are ineffective against prions. As a result, the safest and recommended action is to bag the device as biohazardous waste and discard it, preventing any risk of iatrogenic transmission.

For the CIC® exam, this question tests recognition that manufacturer IFUs do not supersede prion-specific infection prevention guidance, and patient safety requires device destruction when prion exposure cannot be reliably mitigated.

The CBIC Certified Infection Control Exam Study Guide (6th edition) explains that early identification of bioterrorism events or outbreaks caused by emerging pathogens is often challenging because a novel strain of a pathogen may be involved. Novel or emerging pathogens frequently present with nonspecific, influenza-like symptoms that resemble common community-acquired illnesses. As a result, early cases may not immediately raise concern among clinicians or public health authorities.

When a pathogen is novel, it may not be readily detectable using routine diagnostic tests, and clinicians may not initially consider it in their differential diagnosis. In addition, baseline epidemiologic patterns for the organism are often unknown, making it difficult to distinguish unusual disease activity from expected background illness. This delay can occur both in naturally emerging infections and in bioterrorism-related events where the organism or strain may be intentionally unfamiliar or genetically altered.

Option B is less accurate because the primary issue is often lack of recognition, not test sensitivity. Option C is incorrect because a specific number of cases is not required for detection; even a single unusual case can prompt investigation. Option D is incorrect because blood donation surveillance is not the primary mechanism for detecting bioterrorism or emerging infectious disease outbreaks.

For CIC® exam preparation, it is essential to recognize that novel pathogens obscure early recognition, delaying diagnosis, reporting, and response—making option A the most accurate answer.

The CBIC Certified Infection Control Exam Study Guide (6th edition) explains that an interpretive surveillance report goes beyond simply presenting raw data. Its primary purpose is to translate surveillance findings into meaningful, actionable information that can be understood and used by the intended audience, such as frontline staff, clinical leaders, executive leadership, or quality committees.

Interpretive reports contextualize infection data by explaining trends, comparisons, implications, and recommended actions. This may include highlighting increases or decreases in infection rates, identifying areas of concern, interpreting statistical significance, and linking findings to prevention strategies. The format, level of detail, and language are tailored to the audience’s role and decision-making responsibilities. For example, senior leadership may need high-level summaries and risk implications, while unit-level staff benefit from detailed, practice-focused feedback.

Option A describes a mission statement, not a surveillance report. Option B refers to program evaluation logistics rather than interpretation of findings. Option C outlines quality improvement processes but does not describe how surveillance data are communicated.

For the CIC® exam, it is essential to recognize that interpretive surveillance reporting focuses on meaningful communication, not just data display. Providing findings in a manner designed for the intended audience ensures surveillance data drive prevention actions, accountability, and performance improvement—making option D the best answer.

The CDC recommends exclusion of healthcare workers with pertussis until completing at least five days of antibiotic therapy​.

CBIC Infection Control References:

APIC-JCR Workbook, "Occupational Health Considerations," Chapter 10​